Fig. 1From: Pilot randomized trial of short-term changes in inflammation and lipid levels during and after aspirin and pravastatin therapyTrajectories of hsCRP among women with baseline hsCRP between 2 and 10 mg/L. Each series represents one participant; data are individual measurements of hsCRP in mg/L. Women were randomized to receive either daily aspirin, pravastatin, or both from baseline to week 2, followed by a washout period from week 2 to week 4Back to article page